NCT01589133View on ClinicalTrials.gov

Surgiscreen Registration

CompletedOBSERVATIONAL
Enrollment

3,109

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Irregular Antibody Screening
Trial Locations (4)

100021

Cancer Institute & Hospital, Chinese Academy of Medical Science, Beijing

100034

Peking University First Hospital, Beijing

200003

Shanghai Changzheng Hospital, Shanghai

200051

Shanghai Blood Center, Shanghai

Sponsors
All Listed Sponsors
lead

Johnson & Johnson Medical, China

INDUSTRY